Abstract
Hepatitis A virus (HAV) has an immunodominant neutralization antigenic site. By using a panel of monoclonal antibodies targeted against the HAV neutralization antigenic site, it was shown that three epitopes within this site are present on 14S subunits (pentamers of the structural unit). In contrast, two other epitopes within this site are formed upon assembly of 14S subunits into capsids. Thus, the epitopes recognized by these two monoclonal antibodies are formed either by a conformational change in the antigenic site or by the juxtaposition of epitope fragments present on different 14S subunits during assembly of 14S into 70S particles. Both 14S and 70S particles elicited HAV-neutralizing antibodies in mice; thus, these particles may be useful for HAV vaccine development.
Full text
PDF





Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson D. A., Ross B. C. Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles. J Virol. 1990 Nov;64(11):5284–5289. doi: 10.1128/jvi.64.11.5284-5289.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen J. I., Ticehurst J. R., Purcell R. H., Buckler-White A., Baroudy B. M. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol. 1987 Jan;61(1):50–59. doi: 10.1128/jvi.61.1.50-59.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coulepis A. G., Veale M. F., MacGregor A., Kornitschuk M., Gust I. D. Detection of hepatitis A virus and antibody by solid-phase radioimmunoassay and enzyme-linked immunosorbent assay with monoclonal antibodies. J Clin Microbiol. 1985 Jul;22(1):119–124. doi: 10.1128/jcm.22.1.119-124.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flehmig B. Hepatitis A virus in cell culture. II. Growth characteristics of hepatitis A virus in Frhk-4/R cells. Med Microbiol Immunol. 1981;170(2):73–81. doi: 10.1007/BF02122671. [DOI] [PubMed] [Google Scholar]
- Foriers A., Rombaut B., Boeyé A. Use of high-performance size-exclusion chromatography for the separation of poliovirus and subviral particles. J Chromatogr. 1990 Jan 5;498(1):105–111. doi: 10.1016/s0021-9673(01)84239-4. [DOI] [PubMed] [Google Scholar]
- Lemon S. M., Binn L. N., Marchwicki R. H. Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures. J Clin Microbiol. 1983 May;17(5):834–839. doi: 10.1128/jcm.17.5.834-839.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lemon S. M., Brown C. D., Brooks D. S., Simms T. E., Bancroft W. H. Specific immunoglobulin M response to hepatitis A virus determined by solid-phase radioimmunoassay. Infect Immun. 1980 Jun;28(3):927–936. doi: 10.1128/iai.28.3.927-936.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luo M., Rossmann M. G., Palmenberg A. C. Prediction of three-dimensional models for foot-and-mouth disease virus and hepatitis A virus. Virology. 1988 Oct;166(2):503–514. doi: 10.1016/0042-6822(88)90521-1. [DOI] [PubMed] [Google Scholar]
- MacGregor A., Kornitschuk M., Hurrell J. G., Lehmann N. I., Coulepis A. G., Locarnini S. A., Gust I. D. Monoclonal antibodies against hepatitis A virus. J Clin Microbiol. 1983 Nov;18(5):1237–1243. doi: 10.1128/jcm.18.5.1237-1243.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Page G. S., Mosser A. G., Hogle J. M., Filman D. J., Rueckert R. R., Chow M. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J Virol. 1988 May;62(5):1781–1794. doi: 10.1128/jvi.62.5.1781-1794.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ping L. H., Jansen R. W., Stapleton J. T., Cohen J. I., Lemon S. M. Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8281–8285. doi: 10.1073/pnas.85.21.8281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ping L. H., Lemon S. M. Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol. 1992 Apr;66(4):2208–2216. doi: 10.1128/jvi.66.4.2208-2216.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reynolds C., Page G., Zhou H., Chow M. Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B. Virology. 1991 Sep;184(1):391–396. doi: 10.1016/0042-6822(91)90856-7. [DOI] [PubMed] [Google Scholar]
- Rombaut B., Boeyé A., Ferguson M., Minor P. D., Mosser A., Rueckert R. Creation of an antigenic site in poliovirus type 1 by assembly of 14 S subunits. Virology. 1990 Jan;174(1):305–307. doi: 10.1016/0042-6822(90)90080-b. [DOI] [PubMed] [Google Scholar]
- Rombaut B., Foriers A., Boeyé A. In vitro assembly of poliovirus 14 S subunits: identification of the assembly promoting activity of infected cell extracts. Virology. 1991 Feb;180(2):781–787. doi: 10.1016/0042-6822(91)90091-o. [DOI] [PubMed] [Google Scholar]
- Rombaut B., Vrijsen R., Boeyé A. New evidence for the precursor role of 14 S subunits in poliovirus morphogenesis. Virology. 1990 Jul;177(1):411–414. doi: 10.1016/0042-6822(90)90502-i. [DOI] [PubMed] [Google Scholar]
- Ruchti F., Siegl G., Weitz M. Identification and characterization of incomplete hepatitis A virus particles. J Gen Virol. 1991 Sep;72(Pt 9):2159–2166. doi: 10.1099/0022-1317-72-9-2159. [DOI] [PubMed] [Google Scholar]
- Siegl G., Frösner G. G., Gauss-Müller V., Tratschin J. D., Deinhardt F. The physicochemical properties of infectious hepatitis A virions. J Gen Virol. 1981 Dec;57(Pt 2):331–341. doi: 10.1099/0022-1317-57-2-331. [DOI] [PubMed] [Google Scholar]
- Siegl G., Lemon S. M. Recent advances in hepatitis A vaccine development. Virus Res. 1990 Oct;17(2):75–92. doi: 10.1016/0168-1702(90)90070-r. [DOI] [PubMed] [Google Scholar]
- Stapleton J. T., Frederick J., Meyer B. Hepatitis A virus attachment to cultured cell lines. J Infect Dis. 1991 Dec;164(6):1098–1103. doi: 10.1093/infdis/164.6.1098. [DOI] [PubMed] [Google Scholar]
- Stapleton J. T., Jansen R., Lemon S. M. Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin. Gastroenterology. 1985 Sep;89(3):637–642. doi: 10.1016/0016-5085(85)90462-7. [DOI] [PubMed] [Google Scholar]
- Stapleton J. T., Lange D. K., LeDuc J. W., Binn L. N., Jansen R. W., Lemon S. M. The role of secretory immunity in hepatitis A virus infection. J Infect Dis. 1991 Jan;163(1):7–11. doi: 10.1093/infdis/163.1.7. [DOI] [PubMed] [Google Scholar]
- Stapleton J. T., Lemon S. M. Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J Virol. 1987 Feb;61(2):491–498. doi: 10.1128/jvi.61.2.491-498.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiedermann G., Ambrosch F., Kollaritsch H., Hofmann H., Kunz C., D'Hondt E., Delem A., André F. E., Safary A., Stéphenne J. Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine. 1990 Dec;8(6):581–584. doi: 10.1016/0264-410x(90)90013-c. [DOI] [PubMed] [Google Scholar]
- Winokur P. L., McLinden J. H., Stapleton J. T. The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into viruslike particles. J Virol. 1991 Sep;65(9):5029–5036. doi: 10.1128/jvi.65.9.5029-5036.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Winokur P. L., Stapleton J. T. Immunoglobulin prophylaxis for hepatitis A. Clin Infect Dis. 1992 Feb;14(2):580–586. doi: 10.1093/clinids/14.2.580. [DOI] [PubMed] [Google Scholar]